世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000035578

抗血栓薬の世界市場(2023-2027)

TechNavio

Global Antithrombotic Drugs Market 2023-2027

発刊日 2023/05/24

言語英語

体裁PDF/156ページ

ライセンス/価格156ページ

0000035578

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

抗血栓薬市場は、2022年から2027年の間に231億9,994万米ドル成長すると予測されており、予測期間中にCAGRは8.42%で加速します。抗血栓薬市場に関するレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、凝固障害の有病率の増加、新しい経口抗凝固薬の導入、強力な研究開発パイプラインの構築によって牽引されています。

抗血栓薬市場は次のように分類されます。

  • 投与経路別
    ➣ 経口
    ➣ 注射
  • 流通チャネル別
    ➣ 病院薬局
    ➣ 小売薬局
    ➣ オンライン薬局
  • 地域別
    ➣ 北アメリカ
    ➣ ヨーロッパ
    ➣ アジア
    ➣ 世界のその他の地域

この調査は、抗凝固解毒剤の出現が、今後数年間の抗血栓薬市場の成長を促進する主な理由の1つであることを特定しています。また、市場に焦点を当てた企業の戦略的パートナーシップや買収、および市場に焦点を当てた新たな開発の成長は、市場でのかなりの需要につながるでしょう。

抗血栓薬市場に関するレポートは、次の分野をカバーしています。

  • 抗血栓薬市場の規模
  • 抗血栓薬市場の予測
  • 抗血栓薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。また、抗血栓薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

  • 調査企業
    ➣ Aspen Pharmacare Holdings Ltd
    ➣ AstraZeneca PLC
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ Bristol Myers Squibb Co.
    ➣ Daiichi Sankyo Co. Ltd.
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Fresenius Kabi AG
    ➣ Hikma Pharmaceuticals Plc
    ➣ Novartis AG
    ➣ 大塚製薬工業(Otsuka Pharmaceutical Co. Ltd.)
    ➣ Sanofi SA
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global antithrombotic drugs market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
4.2 Route of Administration Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Route of Administration
6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2022-2027 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2022-2027
Exhibit 34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
6.4 Injectable - Market size and forecast 2022-2027
Exhibit 38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)
Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacy - Market size and forecast 2022-2027
Exhibit 48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
7.4 Retail pharmacy - Market size and forecast 2022-2027
Exhibit 52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
7.5 Online pharmacy - Market size and forecast 2022-2027
Exhibit 56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Aspen Pharmacare Holdings Ltd
Exhibit 111: Aspen Pharmacare Holdings Ltd - Overview
Exhibit 112: Aspen Pharmacare Holdings Ltd - Business segments
Exhibit 113: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibit 114: Aspen Pharmacare Holdings Ltd - Segment focus
12.4 AstraZeneca PLC
Exhibit 115: AstraZeneca PLC - Overview
Exhibit 116: AstraZeneca PLC - Product / Service
Exhibit 117: AstraZeneca PLC - Key news
Exhibit 118: AstraZeneca PLC - Key offerings
12.5 Bayer AG
Exhibit 119: Bayer AG - Overview
Exhibit 120: Bayer AG - Business segments
Exhibit 121: Bayer AG - Key news
Exhibit 122: Bayer AG - Key offerings
Exhibit 123: Bayer AG - Segment focus
12.6 Boehringer Ingelheim International GmbH
Exhibit 124: Boehringer Ingelheim International GmbH - Overview
Exhibit 125: Boehringer Ingelheim International GmbH - Business segments
Exhibit 126: Boehringer Ingelheim International GmbH - Key news
Exhibit 127: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 128: Boehringer Ingelheim International GmbH - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 129: Bristol Myers Squibb Co. - Overview
Exhibit 130: Bristol Myers Squibb Co. - Product / Service
Exhibit 131: Bristol Myers Squibb Co. - Key news
Exhibit 132: Bristol Myers Squibb Co. - Key offerings
12.8 Daiichi Sankyo Co. Ltd.
Exhibit 133: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 134: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 135: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 136: Daiichi Sankyo Co. Ltd. - Key offerings
12.9 Eli Lilly and Co.
Exhibit 137: Eli Lilly and Co. - Overview
Exhibit 138: Eli Lilly and Co. - Product / Service
Exhibit 139: Eli Lilly and Co. - Key news
Exhibit 140: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 141: F. Hoffmann La Roche Ltd. - Overview
Exhibit 142: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 143: F. Hoffmann La Roche Ltd. - Key news
Exhibit 144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 145: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Fresenius Kabi AG
Exhibit 146: Fresenius Kabi AG - Overview
Exhibit 147: Fresenius Kabi AG - Business segments
Exhibit 148: Fresenius Kabi AG - Key news
Exhibit 149: Fresenius Kabi AG - Key offerings
Exhibit 150: Fresenius Kabi AG - Segment focus
12.12 Hikma Pharmaceuticals Plc
Exhibit 151: Hikma Pharmaceuticals Plc - Overview
Exhibit 152: Hikma Pharmaceuticals Plc - Business segments
Exhibit 153: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 154: Hikma Pharmaceuticals Plc - Segment focus
12.13 Novartis AG
Exhibit 155: Novartis AG - Overview
Exhibit 156: Novartis AG - Business segments
Exhibit 157: Novartis AG - Key offerings
Exhibit 158: Novartis AG - Segment focus
12.14 Otsuka Pharmaceutical Co. Ltd.
Exhibit 159: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 160: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibit 161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.15 Sanofi SA
Exhibit 162: Sanofi SA - Overview
Exhibit 163: Sanofi SA - Business segments
Exhibit 164: Sanofi SA - Key news
Exhibit 165: Sanofi SA - Key offerings
Exhibit 166: Sanofi SA - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 170: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 171: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Viatris Inc.
Exhibit 172: Viatris Inc. - Overview
Exhibit 173: Viatris Inc. - Business segments
Exhibit 174: Viatris Inc. - Key news
Exhibit 175: Viatris Inc. - Key offerings
Exhibit 176: Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global antithrombotic drugs market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits31: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Injectable - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Injectable - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Hospital pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Hospital pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Retail pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Retail pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Online pharmacy - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online pharmacy - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ million)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ million)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Aspen Pharmacare Holdings Ltd - Overview
Exhibits112: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits113: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits114: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits115: AstraZeneca PLC - Overview
Exhibits116: AstraZeneca PLC - Product / Service
Exhibits117: AstraZeneca PLC - Key news
Exhibits118: AstraZeneca PLC - Key offerings
Exhibits119: Bayer AG - Overview
Exhibits120: Bayer AG - Business segments
Exhibits121: Bayer AG - Key news
Exhibits122: Bayer AG - Key offerings
Exhibits123: Bayer AG - Segment focus
Exhibits124: Boehringer Ingelheim International GmbH - Overview
Exhibits125: Boehringer Ingelheim International GmbH - Business segments
Exhibits126: Boehringer Ingelheim International GmbH - Key news
Exhibits127: Boehringer Ingelheim International GmbH - Key offerings
Exhibits128: Boehringer Ingelheim International GmbH - Segment focus
Exhibits129: Bristol Myers Squibb Co. - Overview
Exhibits130: Bristol Myers Squibb Co. - Product / Service
Exhibits131: Bristol Myers Squibb Co. - Key news
Exhibits132: Bristol Myers Squibb Co. - Key offerings
Exhibits133: Daiichi Sankyo Co. Ltd. - Overview
Exhibits134: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits135: Daiichi Sankyo Co. Ltd. - Key news
Exhibits136: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits137: Eli Lilly and Co. - Overview
Exhibits138: Eli Lilly and Co. - Product / Service
Exhibits139: Eli Lilly and Co. - Key news
Exhibits140: Eli Lilly and Co. - Key offerings
Exhibits141: F. Hoffmann La Roche Ltd. - Overview
Exhibits142: F. Hoffmann La Roche Ltd. - Business segments
Exhibits143: F. Hoffmann La Roche Ltd. - Key news
Exhibits144: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits145: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits146: Fresenius Kabi AG - Overview
Exhibits147: Fresenius Kabi AG - Business segments
Exhibits148: Fresenius Kabi AG - Key news
Exhibits149: Fresenius Kabi AG - Key offerings
Exhibits150: Fresenius Kabi AG - Segment focus
Exhibits151: Hikma Pharmaceuticals Plc - Overview
Exhibits152: Hikma Pharmaceuticals Plc - Business segments
Exhibits153: Hikma Pharmaceuticals Plc - Key offerings
Exhibits154: Hikma Pharmaceuticals Plc - Segment focus
Exhibits155: Novartis AG - Overview
Exhibits156: Novartis AG - Business segments
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits160: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibits161: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits162: Sanofi SA - Overview
Exhibits163: Sanofi SA - Business segments
Exhibits164: Sanofi SA - Key news
Exhibits165: Sanofi SA - Key offerings
Exhibits166: Sanofi SA - Segment focus
Exhibits167: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits168: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits169: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits170: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits171: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits172: Viatris Inc. - Overview
Exhibits173: Viatris Inc. - Business segments
Exhibits174: Viatris Inc. - Key news
Exhibits175: Viatris Inc. - Key offerings
Exhibits176: Viatris Inc. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations

この商品のレポートナンバー

0000035578

TOP